Estimates Revisions Foresee Pharmaceuticals Co., Ltd.

Stocks

End-of-day quote Taipei Exchange Other stock markets 2026-07-03			5-day change	1st Jan Change
83.20 ^TWD	+2.59%		+6.67%	+3.23%

06-08	Foresee Pharmaceuticals Oral ALDH2 Activator Mirivadelgat Enters Clinical Testing in Parkinson's Disease in the SLEIPNIR Phase 2A Platform Trial	CI
05-27	Foresee Pharmaceuticals Completes Casppian Phase 3 Study and Confirms Topline Results for FP-001 42 Mg in Central Precocious Puberty	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	LONZA GROUP AG
	REVOLUTION MEDICINES, INC.
	IQVIA HOLDINGS INC.
	BEONE MEDICINES AG
	CELLTRION, INC.
	ASCENDIS PHARMA A/S			-
	MEDPACE HOLDINGS, INC.
	EUROFINS SCIENTIFIC SE
	IONIS PHARMACEUTICALS, INC.
	Average
	Weighted average by Cap.